Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Through the Line: Packaging and Processing

Through the Line: Packaging and Processing artwork

The Future of Pharmaceutical Manufacturing: Healthcare Packaging

Sep 11, 202620 minAudio

What's driving the pharmaceutical industry's forecasted addition of 19,000 jobs by 2034? An aging population, breakthrough therapeutics, and a push to reshore production are fueling major growth in domestic pharma manufacturing. While data science and cybersecurity roles are growing fastest, high-volume positions like packaging operators and chemists remain essential, and employers are racing to replace retiring baby boomers while upskilling workers for increasingly automated lines. This is an AI-generated episode. Read the full featured article on Healthcare Packaging.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

SPEAKER_01Welcome to Through the Line, the podcast exploring innovations and information across the packaging and processing landscape. From topics impacting consumer packaged goods and healthcare packaging to the latest technologies in food processing operations.

SPEAKER_00Hi, Luz Cuneo here, editor-in-chief of healthcare packaging. What follows is an AI-generated podcast from a recent article on our site all about the future of pharmaceutical manufacturing. The domestic pharma manufacturing sector is poised for significant expansion with forecasts predicting the addition of 19,000 new jobs by 2034. Listen in to learn why the growth, what sectors specifically, and any new trends around workforce.

SPEAKER_03We are jumping right into a deep dive exploring how a projected boom of 19,000 new U.S. pharmaceutical manufacturing jobs by 2034 is going to directly impact the daily realities and the future careers of packaging, processing, and machinery professionals.

SPEAKER_02And it is a massive shift we are looking at.

SPEAKER_03It really is. Imagine a pharmaceutical factory in 2034, the lights are completely off, there isn't a single human on the production floor, yet millions of life-saving therapeutics are just being flawlessly packaged, verified, and shipped out to the world.

SPEAKER_02Yeah, the classic dark factory concept.

SPEAKER_03Exactly. So is that the inevitable future of your industry, or is it just like a tech investor's pipe dream? Today we are focusing entirely on your world. If you're listening, there's a very good chance you are a professional working in the packaging and processing industry, and we've gathered some highly revealing source material just for you.

SPEAKER_02Aaron Powell We really have. We're pulling from some brand new projections from the U.S. Bureau of Labor Statistics, some fascinating data from the Parsex State of Manufacturing Industry 26 survey, and strategic insights from leaders across the life sciences sector.

SPEAKER_03Aaron Powell Yeah. And our mission today is really to just cut through all the general noise surrounding pharmaceutical growth. We want to figure out exactly what this impending expansion means for you, the people on the floor, managing the equipment, optimizing supply chains, and just keeping the packaging lines running. Okay, let's unpack this.

SPEAKER_02Let's do it.

SPEAKER_03The Bureau of Labor Statistics recently released a forecast, and they are projecting that U.S. pharmaceutical and medicine manufacturing employment is going to grow by 5.4% between 2024 and 2034.

SPEAKER_02Aaron Powell Which is not a small number when you look at the raw data.

SPEAKER_03Aaron Powell Not at all. We're looking at a jump from 350,500 employees to 369,500. So that addition of roughly 19,000 jobs actually makes pharmaceutical manufacturing the eighth fastest growing manufacturing industry in the country.

SPEAKER_02Aaron Powell Yeah, top 10. That is huge.

SPEAKER_03Aaron Powell And to put your role in perspective here, I want you to think of the pharmaceutical industry like this massive global high-end restaurant group.

SPEAKER_02Aaron Powell Okay. I like this.

SPEAKER_03Aaron Powell Think about it. The media and the public naturally focus all their attention on the Michelin star chefs, right? The research scientists and chemists discovering these groundbreaking new drugs.

SPEAKER_02Aaron Powell Sure, the people making the recipes.

SPEAKER_03Exactly. But inventing a great recipe in a test kitchen doesn't feed a million people safely. If you don't have world-class expeditors, logistics experts, and packaging professionals, that product never reaches the patient securely, cleanly, or at the required scale.

SPEAKER_02Aaron Powell No, it just stays in the lab. And that reality is exactly what is driving these numbers. The scientists might create the product, but the packaging and processing teams are the ones who actually make it a viable, deliverable medicine.

SPEAKER_03Aaron Powell, which is why your skills are in such high demand right now.

SPEAKER_02Definitely. And to understand why this massive boom is happening right now, rather than say five years ago or five years in the future, we have to look at the insights from Vince Wong. He's the president and CEO of Bio Crossroads.

SPEAKER_03He had some really interesting points on this.

SPEAKER_02He did. He points out that we aren't just looking at one single trend here. We're looking at a convergence of three massive drivers. First, we have an aging population that just inherently requires more medicines, specifically complex therapeutics for chronic conditions.

SPEAKER_03Yeah, the demographic shift is undeniable. Trevor Burrus, Jr.

SPEAKER_02Second, we're witnessing rapid advances in the science itself. We're moving way beyond traditional pills and capsules into entirely new categories of therapies.

SPEAKER_03Aaron Powell Things like personalized biologics or advanced injectables.

SPEAKER_02Exactly. And those don't just require a standard blister pack. They require highly specific temperature-controlled manufacturing and packaging protocols. And third, and this is perhaps most impactfully for the actual manufacturing floor, there is a massive concentrated focus on reshoring. Trevor Burrus, Jr.

SPEAKER_03The supply chain shocks of the past few years really woke the industry up.

SPEAKER_02Oh, absolutely.

SPEAKER_03Companies are aggressively bringing medicine manufacturing back to the United States to secure their supply chains. They have to guarantee access to critical medicines, regardless of what global trade disruptions were happening.

SPEAKER_02Yeah, you can't have patients waiting on cargo ships.

SPEAKER_03Exactly. So this 5.4% growth isn't just about building more laboratories or hiring more researchers with PhDs. It represents a direct, sustained demand for your specific logistical and mechanical expertise on the production side.

SPEAKER_02Aaron Powell It really does. But that brings us to a really interesting breakdown of who exactly is going to be hired.

SPEAKER_03Yeah, let's look at the actual jobs.

SPEAKER_02When you dive into the Bureau of Labor Statistics data, chemists are technically leading the headcount growth, with an expected addition of about 1,900 positions. The packaging and filling machine operators are right behind them, projected to add about 1,700 jobs.

SPEAKER_03So those traditional operator roles are growing steadily, which makes sense.

SPEAKER_02But here is where it gets wild. The most staggering growth percentages actually don't belong to the operators at all. They belong to the tech and machinery roles supporting them.

SPEAKER_03Yeah, I saw this in the data and it blew my mind.

SPEAKER_02Industrial machinery mechanics are projected to grow by 26.1%. Information security analysts are looking at 25% growth. And data scientists are projected to explode by 31.3%.

SPEAKER_03Okay, I have to stop and question this specific grouping, though, because why are old school hands-on mechanical roles growing at the exact same explosive rate as highly digital screen-based cybersecurity and data roles? That sounds more like Silicon Valley than a packaging plant.

SPEAKER_02What's fascinating here is that the distinction between Silicon Valley and the modern manufacturing floor is practically gone.

SPEAKER_03Really? Completely gone.

SPEAKER_02Pretty much. We have this lingering tendency to separate the mechanic holding a wrench from the analyst typing on a laptop, but the modern packaging line has permanently merged those two realities. These aren't isolated trends, they're the exact same trend.

SPEAKER_03Okay, walk me through that.

SPEAKER_02Think about a contemporary high-speed filling machine on your floor today, compared to one from 20 years ago. To use an analogy, look at the automotive industry. In the 1990s, if your car broke down, the mechanic grabbed a physical toolbox. A wrench and some grease. Today, the very first thing a mechanic grabs is a laptop to plug into the dashboard just to read the computer's error codes. The packaging floor has gone through the exact same evolution, but on a massive industrial scale.

SPEAKER_03Oh wow, I never thought about it like that.

SPEAKER_02Yeah, a modern filling machine is essentially a giant IoT device. It's packed with sensors, connected to a broader localized network, and it's constantly feeding real-time production metrics back to a central database.

SPEAKER_03So if that machine jams or goes out of calibration, you aren't just fixing a broken gear anymore. You're basically debugging the machine's central nervous system.

SPEAKER_02Precisely. You don't just need a traditional mechanic. You need an advanced industrial machinery mechanic who understands both the physical pneumatics and the digital diagnostics. Furthermore, because that machine is networked and constantly transmitting highly proprietary production data that includes batch records, quality control metrics, regulatory compliance logs, you simultaneously require advanced information security to protect those systems from cyber threats.

SPEAKER_03Because a ransomware attack on a packaging line could shut down production for weeks.

SPEAKER_02Exactly. So you simply cannot have the automated machinery without the mechanic to maintain it, the data scientist to optimize its output, and the security analyst to protect its network. They operate as a single, interdependent ecosystem.

SPEAKER_03Which completely shatters the stereotype of what it means to work in manufacturing today. And the frustrating part is the public perception is lagging decades behind the reality of the work.

SPEAKER_02It really is.

SPEAKER_03The Parsec State of Manufacturing Industry 2026 survey highlights this exact tension. They surveyed 1,200 global manufacturing leaders. And get this 59% of respondents said that manufacturing suffers from an inaccurate perception as a labor-intense low-skill industry.

SPEAKER_02And that lingering myth makes it incredibly difficult to recruit top talent.

SPEAKER_03Totally. Yet in that exact same survey, 72% of those leaders stated that upskilling their existing workforce is critical to their long-term viability over the next three years. This clearly signals that your job, the listener's job, is fundamentally evolving from manual oversight to managing sophisticated, data-driven, smart operations.

SPEAKER_02The operators and mechanics of today are essentially frontline technologists.

SPEAKER_03Yeah.

SPEAKER_02But that requirement for advanced skills brings us to a major structural roadblock.

SPEAKER_03The labor shortage.

SPEAKER_02Exactly. Building all these highly secure network machines in the U.S. is completely useless if there's no one left to actually run them. Across all manufacturing sectors, not just pharma, the Bureau of Labor Statistics estimates that employers will need to fill nearly one million production openings annually through 2034.

SPEAKER_03One million annually? That is a massive number.

SPEAKER_02It's huge. And at the exact same time, the Parsec survey reveals that 70% of those 1,200 global manufacturing leaders have either completed or in the process of reshoring their operations. So we are simultaneously demanding more highly skilled workers to run incredibly advanced facilities while physically moving more of those facilities back to American soil.

SPEAKER_03And the talent pool just isn't there to meet both demands at once. It's honestly like trying to build a massive state-of-the-art smart city, but all your veteran engineers are retiring at the exact same time, and the new recruits don't realize how high-tech the job actually is, so they aren't even applying.

SPEAKER_02Yeah, that's a great way to put it. And if we connect this to the bigger picture, we can see what Vince Wong accurately describes as a demographic collision.

SPEAKER_03A demographic collision, I like that term.

SPEAKER_02It perfectly captures it. It's a perfect storm of labor shortages. It's the collision of the baby boomer generation reaching retirement age and taking decades of irreplaceable institutional knowledge with them. You combine that with steadily declining birth rates across the general population, meaning fewer young workers entering the labor force overall. Then you add restrictive immigration policies that limit the influx of new skilled talent from abroad.

SPEAKER_03It really is a perfect storm.

SPEAKER_02And finally, you have that declining workforce participation rate among younger generations who have been influenced by that false low skill perception we just talked about.

SPEAKER_03So bringing manufacturing back to the U.S. through reshoring is colliding directly with this shrinking, aging talent pool.

SPEAKER_02Yes. And it's important to note that the majority of those 1 million annual openings aren't entirely new roles created by expansion. They are replacement roles for veteran workers who are permanently leaving their occupations.

SPEAKER_03The industry is clearly recognizing this threat, though, and they're starting to fight back aggressively. Our sources detail several structured initiatives designed to rebuild this talent pipeline from the ground up.

SPEAKER_02Yeah, they really have to.

SPEAKER_03Like Bio Crossroads and its partners in Indiana, for example. They're implementing highly targeted programs aimed at multiple demographics, K-12 students, college students, and working adults. They are trying to build clear, visible career pathways, specifically into the life sciences and healthcare sectors.

SPEAKER_02They want to show a high schooler that running a robotic packaging line is closer to programming than it is to manual labor.

SPEAKER_03Exactly. And on a national level, PMMI, the Association for Packaging and Processing Technologies, they recently contributed to the MicroRowks Foundation's 2026 scholarship program.

SPEAKER_02Oh, that's a great initiative.

SPEAKER_03It really is. It specifically invests in workforce development, creating financial pathways for individuals to pursue careers in technical and skilled trades. They are actively trying to rebrand the profession. For you, the listener, this data is incredibly empowering.

SPEAKER_02It puts you in a very strong position.

SPEAKER_0356% of the Parsec respondents noted that reshoring directly increases the demand for skilled labor. This demographic collision and the resulting labor shortage mean your existing processing and packaging skills are about to be at a historic premium.

SPEAKER_02That premium is undeniable. The massive investments being poured into workforce development right now prove just how desperate companies are to secure and retain human talent for these modernized floors.

SPEAKER_03Definitely.

SPEAKER_02However, we have to look at the entire landscape here. It is vital to acknowledge that not everyone in the industry believes this reliance on human operators will last indefinitely.

SPEAKER_03There's always another side to the coin.

SPEAKER_02There is a very different counter-narrative merging from technology-focused capital investors. This perspective challenges the long-term validity of these employment projections, suggesting that the current hiring boom might just be a transitional phase.

SPEAKER_03And that brings us to Haider Alleg, the managing director at Kindju and general partner at Allegory Capital. His perspective completely flips the script on everything we just discussed.

SPEAKER_02It really does. It's a totally different vision.

SPEAKER_03Alleg claims that this job growth in packaging and processing is strictly temporary. He states that thanks to artificial intelligence, the industry might actually discover fewer new drugs in the future, but will require entirely new, highly complex models to produce and combine the ones we already have.

SPEAKER_02And because of that complexity, he predicts the eventual rise of what he calls dark factories in pharma.

SPEAKER_03These would be fully automated lights out facilities operating entirely without human intervention, similar to what we already see in certain fast-moving consumer goods or FMCG giants.

SPEAKER_02Which is a bold claim.

SPEAKER_03No, wait a minute. A completely dark factory, no humans on the floor at all. I have to push back on that. It's one thing to have a lights out factory that bottles water or packages consumer electronics, but in pharmaceuticals?

SPEAKER_02Yeah, the stakes are a bit higher.

SPEAKER_03The FDA would have an absolute field day with that. Given the intense compliance regulations, the track and trace mandates, and the sheer quality control required, how is a true dark factory actually realistic? Or is this just provocative technological optimism from a venture capital perspective?

SPEAKER_02Aaron Powell That is the pivotal question. And it's the core of the debate happening right now in pharmaceutical leadership. And just to be clear, we are simply exploring both Alex and the BLS's differing viewpoints here without endorsing one over the other as absolute fact. We want to give you the full picture.

SPEAKER_03Aaron Powell Exactly. We're just looking at what the sources are saying.

SPEAKER_02Aaron Powell So Alex's vision is definitely provocative, especially when you stack it up against the BLS's 10-year outlook. We have to look at both timelines to see where the truth might lie. The Bureau of Labor Statistics is working on a strictly defined 10-year horizon from 2024 to 2034.

SPEAKER_03Okay, so a relatively near-term view.

SPEAKER_02Yes. And within that specific window, their data heavily supports the idea that humans remain absolutely essential. You need humans running the complex machines, navigating immediate FDA compliance audits, validating the digitizing manufacturing data, and ensuring batch integrity. Trevor Burrus, Jr.

SPEAKER_03Because the regulatory environment of pharmaceuticals where a single packaging error or cross-contamination can literally be a matter of life or death, it requires a level of human accountability and legal liability that FMCG products simply do not.

SPEAKER_02Exactly. You can't just hand regulatory sign-off over to an algorithm today.

SPEAKER_03Yeah. The FDA isn't going to accept a signature from an AI.

SPEAKER_02No, they are not. However, Alley is looking a decade or two past that horizon. He is anticipating a point where AI, machine learning, and advanced robotics reach a level of proven reliability that eventually satisfies even the most stringent regulatory bodies.

SPEAKER_03Ah, okay. So he's basically saying that while the BLS is looking at the next 10 years, he's looking at year 15 or 20 when the AI can finally prove to the FDA that it makes fewer mistakes than a human operator.

SPEAKER_02Exactly. If dark factories eventually become a certified reality in pharmaceuticals, the demand shifts entirely. The industry will no longer need packaging machine operators in the traditional sense, or even in the hybridized tech mechanics sense we see today. Instead, the demand will transition almost entirely to algorithm managers, AI systems auditors, and advanced robotics maintenance engineers who only occasionally step into the dark factory to physically service the automated infrastructure when the AI flags mechanical degradation.

SPEAKER_03Wow. We have covered a tremendous amount of ground in this analysis. We started with the projection of 19,000 new U.S. pharmaceutical manufacturing jobs, and your central role is the vital expediter of this industry's massive growth.

SPEAKER_02We toured a lot, yeah.

SPEAKER_03We examined the evolution of the high-tech packaging mechanic, exploring how modern filling machines require a seamless blend of physical repair and digital cybersecurity expertise. We looked at the demographic collision, where a massive reshoring rush is slamming into an aging retiring workforce, creating a historic premium for your skills.

SPEAKER_02Which is great news for our listeners today.

SPEAKER_03Definitely. And finally, we explored the looming long-term debate over whether advanced AI will eventually replace this current labor boom with automated, lights out, dark factories. So, what does this all mean?

SPEAKER_02It's the million-dollar question.

SPEAKER_03It means that right now, for the next decade at least, you are the hidden star of pharma's explosive growth. Your ability to navigate the modernization of the manufacturing floor, combining mechanical intuition with digital fluency, is the exact skill set the industry is desperately trying to recruit, train, and retain.

SPEAKER_02And as we conclude, I want to leave you with one final thought to consider regarding the long-term future of your career?

SPEAKER_03Let's hear it.

SPEAKER_02We discussed how your role today is the vital link ensuring the product safely reaches the patient. But as the industry inevitably inches closer to a leg's vision of automated dark factories, consider how your expertise must adapt.

SPEAKER_03Adapt how, exactly.

SPEAKER_02This raises an important question. Will the ultimate competitive advantage for a packaging professional in 2034 no longer be knowing how to physically run a complex machine, but rather knowing how to audit, troubleshoot, and expertly teach the artificial intelligence that runs the factory for you?

SPEAKER_03Oh, that's fascinating.

SPEAKER_02Think about it. The deep intuitive experience you are gaining on the floor today, understanding the quirks of the materials, the environmental variables, the subtle sounds of a machine running perfectly, that might be the exact training data, the AI of tomorrow desperately needs to function.

SPEAKER_03That is a brilliant way to look at it. You aren't just operating a machine today, you are learning the language that will eventually train the automation of tomorrow. Thank you for joining us for this deep dive into the future of pharmaceutical packaging and processing. We appreciate your time, your expertise, and your dedication to the industry.

SPEAKER_02Thanks for listening and keep pushing the industry forward.

SPEAKER_01Thank you for listening to Through the Line Packaging and Processing. You can listen to more episodes on all streaming platforms. Be sure to visit us at packworld.com, profoodworld.com, and healthcarepackaging.com for more packaging and processing news. This podcast was edited by Bree Guns.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Why the NDC-12 Deadline is a Hard Stop for Pharma Packaging Lines: Healthcare Packaging

    Nov 20, 202625 minAudio

    What happens to a pharma packaging line when the industry runs out of 10-digit drug codes? Listen in to hear why the FDA’s move to a 12-digit National Drug Code by 2033 can’t be extended, and how the denser 2D barcodes...

    Credit the people on this episode

  2. Traceability in an Uncertain Regulatory Environment: ProFood World

    Nov 18, 202625 minAudio

    Why are food manufacturers still investing in lot-level traceability when the FDA has pushed back its deadline by 30 months? This episode looks at how retail mandates from companies like Walmart are setting the real...

    Credit the people on this episode

  3. Why Recycling can’t Keep Pace with Packaging Innovation: Packaging World

    Nov 17, 202619 minAudio

    Why does the U.S. recycling system always seem to be playing catch-up with packaging design? Senior editor Anne Marie Mohan sits down with Cody Marshall, chief programs officer at The Recycling Partnership, about the...

    Credit the people on this episode

  4. Interlocking Bottles, Retro Castile Soap, and the Push to Go Paperless in Packaging: End of the Line

    Nov 16, 202626 minAudio

    Could a QR code one day replace the paper leaflet in the box? In this week’s End of the Line, PMMI Media Group editors Matt Reynolds, Derrick Teal, Anne Marie Mohan, and Casey Flanagan sit down for a weekly roundup....

    Credit the people on this episode

  5. BayCare Trials Drone Delivery for Pharmaceutical Packaging: Healthcare Packaging

    Nov 13, 202612 minAudio

    How do you ensure a medication arrives at the proper temperature and uncompromised when its trip takes place by air rather than by delivery vehicle? BayCare Health System, a not-for-profit academic healthcare system in...

    Credit the people on this episode